Videos

Case 4: EGFR Mutation Analysis Post-Osimertinib

September 12th 2018

Case 4: Upfront Osimertinib in Metastatic EGFR+ NSCLC

September 12th 2018

Case 4: Metastatic EGFR+ NSCLC Progressing on Osimertinib

September 12th 2018

Case 3: Considerations for Second-Line Therapy in Stage IV NSCLC

September 12th 2018

Case 3: Second-Line Therapy After Chemo/I-O in Stage IV NSCLC

September 12th 2018

Case 3: Tissue & Plasma Sampling in Stage IV NSCLC

September 12th 2018

Case 3: Rapidly Progressing Stage IV NSCLC Following I-O

September 12th 2018

Case 2: Treatment Considerations in Stage IV NSCLC

September 12th 2018

Case 2: Biomarkers and Treatment Decisions in Stage IV NSCLC

September 12th 2018

Case 2: Frontline Treatment Data in Stage IV NSCLC

September 12th 2018

Case 2: Stage IV PD-L1-Negative, KRAS-Mutant Lung Adenocarcinoma

September 12th 2018

Case 1: I-O Therapy & Autoimmune Conditions in NSCLC

September 12th 2018

Case 1: Consolidation Therapy in Locally Advanced NSCLC

September 12th 2018

Case 1: Molecular Testing in Locally Advanced NSCLC

September 12th 2018

Case 1: Immunotherapy in Locally Advanced NSCLC

September 12th 2018

Case 1: Locally Advanced Squamous Non-Small Cell Lung Cancer

September 12th 2018

Management of Advanced NSCLC

September 12th 2018

Convenience of Oral Regimen for the Treatment of MM

September 10th 2018

IRd Triplet for Relapsed Multiple Myeloma

September 10th 2018

Relapsed Multiple Myeloma: Second-Line Approaches

September 10th 2018

Initiation of Second-Line Treatment in Multiple Myeloma

September 10th 2018

Nontransplant Treatment Approaches in Multiple Myeloma

September 10th 2018

Frontline Treatment with RVd for Multiple Myeloma

September 10th 2018

Case Review: MM with High-Risk Cytogenetics

September 10th 2018

Treatment of Multiple Myeloma with High-Risk Cytogenetics

September 10th 2018

Treatment of Multiple Myeloma with High-Risk Cytogenetics

Evolving Treatment Approaches in Stage 4 Gastric Cancer

September 10th 2018

HER2+ Gastric Cancer: Optimal Treatment Approaches

September 10th 2018

Systemic Therapy in PD-L1-Positive Gastric Cancer

September 10th 2018

Optimal Supportive Care for Metastatic Gastric Cancer

September 10th 2018

Gastric Cancer: Paclitaxel/Ramucirumab vs Chemotherapy

September 10th 2018